Ikarian Capital »

Catalyst Pharmaceutical Partners shares owned by Ikarian Capital

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.3M 418k 19.88
2024-06-30 $8.0M 518k 15.49
2024-03-31 $8.3M 518k 15.94
2023-12-31 $8.5M 506k 16.81
2023-09-30 $5.9M 506k 11.69

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
Deerfield Management Company
State Street Corporation
Dimensional Fund Advisors
Pacer Advisors
Geode Capital Management
Renaissance Technologies
First Trust Advisors
Royce & Associates
Goldman Sachs Group
Northern Trust
Robeco Investment Management
T. Rowe Price Associates
Charles Schwab Investment Management

View all funds holding Catalyst Pharmaceutical Partners